Characterization of Candida parapsilosis complex strains isolated from invasive fungal infections
- 10 April 2011
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 30 (11) , 1437-1441
Abstract
In the present work, we studied the distribution of Candida parapsilosis complex species and the antifungal susceptibility of clinical isolates collected during an Italian surveillance study of yeast invasive fungal infections (IFIs) in intensive care units (ICUs). Minimum inhibitory concentrations (MICs) were determined using the Clinical and Laboratory Standards Institute (CLSI) reference broth microdilution method. BanI digestion patterns of the secondary alcohol dehydrogenase polymerase chain reaction (PCR) products were used to identify C. parapsilosis sensu stricto, C. orthopsilosis, and C. metapsilosis. A total of 138 C. parapsilosis isolates were stored (January 2007–December 2008). The overall frequency of C. parapsilosis complex in IFIs was 22%. Of the 138 tested isolates, 95% were C. parapsilosis sensu stricto, 3.6% were C. orthopsilosis, and 1.4% were C. metapsilosis. The MIC50 values (expressed as μg/ml) for anidulafungin, caspofungin, and micafungin for C. parapsilosis complex were 2, 1, and 2, respectively, and the MIC90 values were 4, 2, and 4, respectively. The MIC50 and MIC90 values for itraconazole and posaconazole were 0.12 and 0.25, respectively, and for fluconazole, they were 1 and 4, respectively. This study, the most comprehensive study conducted to date to evaluate the frequency and antifungal susceptibility profiles of C. parapsilosis complex isolates from critically ill patients in Italy, highlights the low prevalence of C. orthopsilosis and C. metapsilosis in IFIs.Keywords
This publication has 21 references indexed in Scilit:
- Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)Diagnostic Microbiology and Infectious Disease, 2011
- Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida sppJournal of Clinical Microbiology, 2010
- Prevalence, Distribution, and Antifungal Susceptibility Profiles of Candida parapsilosis , C. orthopsilosis , and C. metapsilosis in a Tertiary Care HospitalJournal of Clinical Microbiology, 2009
- Geographic Distribution and Antifungal Susceptibility of the Newly Described Species Candida orthopsilosis and Candida metapsilosis in Comparison to the Closely Related Species Candida parapsilosisJournal of Clinical Microbiology, 2008
- A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in Candida parapsilosis , Candida orthopsilosis , and Candida metapsilosis Accounts for Reduced Echinocandin SusceptibilityAntimicrobial Agents and Chemotherapy, 2008
- In Vitro Activity of Anidulafungin against Candida albicans BiofilmsAntimicrobial Agents and Chemotherapy, 2008
- Prevalence and Susceptibility Profile of Candida metapsilosis and Candida orthopsilosis : Results from Population-Based Surveillance of Candidemia in SpainAntimicrobial Agents and Chemotherapy, 2008
- Differential Activities of Newer Antifungal Agents against Candida albicans and Candida parapsilosis BiofilmsAntimicrobial Agents and Chemotherapy, 2008
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Epidemiology, Risk Factors, and Prognosis of Candida parapsilosis Bloodstream Infections: Case-Control Population-Based Surveillance Study of Patients in Barcelona, Spain, from 2002 to 2003Journal of Clinical Microbiology, 2006